# Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion

Study · id `cardio:ct-nct07519044` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07519044](<https://clinicaltrials.gov/study/NCT07519044>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07519044

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 868 participants.

## Technical summary

Registry record NCT07519044. Randomized; double masking; primary purpose treatment. Start 2026-05-14 (actual); primary completion 2027-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 868 participants (planned count; ClinicalTrials.gov record NCT07519044, source copy `cardio:ctgov-nct07519044-2026-06-24`, retrieved 2026-10-26)
- Started: 2026-05-14 (actual) (ClinicalTrials.gov record NCT07519044, source copy `cardio:ctgov-nct07519044-2026-06-24`, retrieved 2026-10-26)
- Primary completion: 2027-01-31 (anticipated) (ClinicalTrials.gov record NCT07519044, source copy `cardio:ctgov-nct07519044-2026-06-24`, retrieved 2026-10-26)
- Completion: 2028-08-31 (anticipated) (ClinicalTrials.gov record NCT07519044, source copy `cardio:ctgov-nct07519044-2026-06-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07519044, source copy `cardio:ctgov-nct07519044-2026-06-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07519044-2026-06-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion
- Acronym: IAT-GIANT
- Condition: Stroke
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Intravenous GM1 Therapy
- Intervention (Drug): Placebo Therapy
- Lead sponsor: Xuanwu Hospital, Beijing
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Xuanwu Hospital, Beijing (`cardio:org-xuanwu-hospital-beijing`)

## Provenance

Content hash: 03fb65fca526a4273084fa05701cecfe051af2870bbee6d00d85eeef105963d2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
